Cost effectiveness of influenza vaccination for healthy persons between ages 65 and 74 years

This publication has 23 references indexed in Scilit:

• The health and economic benefits of influenza vaccination for healthy and at-risk persons aged 65 to 74 years.
  PharmacoEconomics, 1999
• Ten-year durability and success of an organized program to increase influenza and pneumococcal vaccination rates among high-risk adults
  The American Journal of Medicine, 1998
• Benefits of Influenza Vaccination for Low-, Intermediate-, and High-Risk Senior Citizens
  Archives of internal medicine (1960), 1998
• The impact of influenza epidemics on mortality: introducing a severity index.
  American Journal of Public Health, 1997
• Influenza vaccination in 22 developed countries: an update to 1995
  Vaccine, 1997
• The number needed to treat: a clinically useful measure of treatment effect
  BMJ, 1995
• The Efficacy and Cost Effectiveness of Vaccination against Influenza among Elderly Persons Living in the Community
  New England Journal of Medicine, 1994
• Exporting a Successful Influenza Vaccination Program from a Teaching Hospital to a Community Outpatient Setting
  Journal of the American Geriatrics Society, 1992
• Influenza: Relation of Mortality to Morbidity Parameters-Netherlands, 1970—1989
  International Journal of Epidemiology, 1991
• Excess Deaths Attributable to Influenza in England and Wales: Age at Death and Certified Cause
  International Journal of Epidemiology, 1983